A superbug outbreak at UCLA has prompted the family of a patient who died in January 2015 to bring suit against a medical device maker, Olympus Corp. of the Americas, for wrongful death.
The family of 41-year-old Silvia Patricia Aroche filed the lawsuit on March 13, 2015 in Los Angeles Superior Court. According to court documents, the woman was exposed to the deadly CRE bacteria from a contaminated Olympus duodenoscope at UCLA’s Ronald Reagan Medical Center while undergoing multiple procedures in December 2014.
CRE stands for carbapenem-resistant Enterobacteriaceae, a bacteria that is highly resistant to antibiotics and is estimated to have the ability to kill up to 50 percent of infected patients, according to the Centers for Disease Control and Prevention (CDC).
Healthy people do not typically get CRE infections. Instead, they usually happen to patients in hospitals, nursing homes, and other healthcare settings, and those most at risk for contracting a CRE infection include those whose care requires certain devices, including:
Those who are taking long courses of certain antibiotics are also considered to be at risk for CRE.
The Olympus duodenoscopes are typically used to perform a medical procedure known as endoscopic retrograde cholangiopancreatography (ERCP), during which a doctor threads the thin device down the patient’s throat to examine and treat conditions such as cancer, gallstones, and other digestive system issues. After the UCLA infestations, the U.S. Food and Drug Administration warned hospitals that the duodenoscopes are hard to rid of dangerous bacteria, even when following the manufacturers’ directions for reprocessing.
Five lawsuits have been filed against Olympus over contaminated Olympus duodenoscopes thus far. According to the company, seven patients in all were infected with the CRE superbug from scopes made by Olympus, leading to two deaths and exposing an estimated 179 other patients from October 3, 2014 to January 28, 2015.